MCID: NRG005
MIFTS: 22

Neurogenic Hypertension malady

Categories: Rare diseases, Neuronal diseases

Aliases & Classifications for Neurogenic Hypertension

About this section

Aliases & Descriptions for Neurogenic Hypertension:

Name: Neurogenic Hypertension 45 65

Classifications:



External Ids:

UMLS65 C0597048

Summaries for Neurogenic Hypertension

About this section
MalaCards based summary: Neurogenic Hypertension is related to hepatitis and leukemia. An important gene associated with Neurogenic Hypertension is ACE2 (Angiotensin I Converting Enzyme 2), and among its related pathways are Peptide hormone metabolism and Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics. Affiliated tissues include brain, kidney and spinal cord.

Related Diseases for Neurogenic Hypertension

About this section

Graphical network of the top 20 diseases related to Neurogenic Hypertension:



Diseases related to neurogenic hypertension

Symptoms for Neurogenic Hypertension

About this section

Drugs & Therapeutics for Neurogenic Hypertension

About this section

Drugs for Neurogenic Hypertension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Antibiotics, AntitubercularPhase 35971
2Anti-Bacterial AgentsPhase 3, Phase 1, Phase 29140
3Omega 3 Fatty AcidNutraceuticalPhase 3912
4carnitineNutraceuticalPhase 3146
5
FesoterodineapprovedPhase 260286930-03-86918558
Synonyms:
FESO
 
Fesoterodine
Fesoterodine Fumarate
Toviaz
6
Minocyclineapproved, investigationalPhase 1, Phase 217310118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
HMS2090D03
HSDB 3130
LMPK07000002
 
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline
Minocycline (USAN/INN)
Minocycline Hydrochloride
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
NCGC00178854-01
NSC 141993
NSC141993
Solodyn
UNII-FYY3R43WGO
Vectrin (Hydrochloride)
Ximino
minociclinum
minocycline
nchembio.559-comp1
7Anti-Infective AgentsPhase 1, Phase 217220
8Neurotransmitter AgentsPhase 214795
9Cholinergic AntagonistsPhase 21423
10Cholinergic AgentsPhase 23243
11Muscarinic AntagonistsPhase 2961

Interventional clinical trials:

idNameStatusNCT IDPhase
1Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in ChildrenRecruitingNCT02192580Phase 3
2L-carnitine on the Prevention of Renal Scarring in Acute PyelonephritisRecruitingNCT02007889Phase 3
3Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI)RecruitingNCT02676154Phase 2
4Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive PatientsNot yet recruitingNCT02133885Phase 1, Phase 2
5Study 1: Effect of Minocycline Treatment on Drug-Resistant Hypertensive PatientsRecruitingNCT02133872Phase 1
6Study 3: Minocycline Decreases Microglia ActivationNot yet recruitingNCT02213575Phase 1
7Adolescent Blood Pressure Variation and Ventricular MassCompletedNCT00005200
8Brain fMRT In Takotsubo CardiomyopathyRecruitingNCT02240056

Search NIH Clinical Center for Neurogenic Hypertension

Genetic Tests for Neurogenic Hypertension

About this section

Anatomical Context for Neurogenic Hypertension

About this section

MalaCards organs/tissues related to Neurogenic Hypertension:

33
Brain, Kidney, Spinal cord, Prostate, Liver, Breast, Lymph node

Animal Models for Neurogenic Hypertension or affiliated genes

About this section

Publications for Neurogenic Hypertension

About this section

Articles related to Neurogenic Hypertension:

(show top 50)    (show all 131)
idTitleAuthorsYear
1
Recanalization of basilar artery occlusion. (26219271)
2015
2
The global epidemiology of hereditary ataxia and spastic paraplegia: what are the messages? (24603355)
2014
3
Poststroke spasticity: Treating to the disability. (23437441)
2013
4
Regional and seasonal response of a West Nile virus vector to climate change. (24019459)
2013
5
Common variable immunodeficiency - new insight into the pathogenesis and the quest for a workable classification. (23830379)
2013
6
Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. (23607977)
2013
7
The spleen is a player in portal hypertension. (22932277)
2012
8
Molecular typing of Coxiella burnetii (Q fever). (22711642)
2012
9
Pregnenolone sulfate activates basic region leucine zipper transcription factors in insulinoma cells: role of voltage-gated Ca2+ channels and transient receptor potential melastatin 3 channels. (21948387)
2011
10
Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells. (20338593)
2011
11
Suppression of the immune response to FVIII in hemophilia A mice by transgene modified tolerogenic dendritic cells. (21772255)
2011
12
A missense mutation in LRR8 of RXFP2 is associated with cryptorchidism. (20963592)
2010
13
Plasma copeptin and the risk of diabetes mellitus. (20439785)
2010
14
High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. (19515015)
2010
15
Long-term ginsenoside administration prevents memory impairment in aged C57BL/6J mice by up-regulating the synaptic plasticity-related proteins in hippocampus. (19428650)
2009
16
BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases. (19543317)
2009
17
Refinement of the MYP3 locus on human chromosome 12 in a German family with Mendelian autosomal dominant high-grade myopia by SNP array mapping. (18360688)
2008
18
Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1. (17526016)
2007
19
Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia. (18057866)
2007
20
Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer. (16652382)
2006
21
Novel clinical staging for patients with end-stage gastrointestinal carcinoma. (16378189)
2006
22
Impairment of antioxidant enzymes, lipid peroxidation and 8-oxo-2'-deoxyguanosine in advanced epithelial ovarian carcinoma of a Spanish community. (15899547)
2006
23
Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome. (15778926)
2005
24
What do epidemiologic studies tell us about hyperuricemia and cardiovascular disease and death? (15918997)
2005
25
West Nile virus meningoencephalitis in an immunocompetent adolescent. (16139740)
2005
26
Countermeasures to the bioterrorist threat of smallpox. (16375715)
2005
27
Deafness and cochlear fibrocyte alterations in mice deficient for the inner ear protein otospiralin. (15632083)
2005
28
Molecular analysis of an immature ovarian teratoma with gliomatosis peritonei and recurrence suggests genetic independence of multiple tumors. (15201985)
2004
29
Associations between the human insulin gene 5' VNTR and clinical variables of the renin-angiotensin system. (14647005)
2003
30
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial. (12384156)
2002
31
Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome. (11992770)
2002
32
alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1. (11591509)
2001
33
Autosomal recessive tetralogy of Fallot, unusual facies, communicating hydrocephalus, and delayed language development: a new syndrome? (11152158)
2001
34
Diagnosis: acrodermatitis continua of Hallopeau. (11294139)
2001
35
Import of peroxisomal matrix and membrane proteins. (10966464)
2000
36
Cloning, expression, and characterization of human cytosolic aminopeptidase P: a single manganese(II)-dependent enzyme. (11106490)
2000
37
Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma. (10627649)
1999
38
Clinically prescribed sunscreen (sun protection factor 15) does not decrease serum vitamin D concentration sufficiently either to induce changes in parathyroid function or in metabolic markers. (9767286)
1998
39
Midazolam via the intranasal route: an effective rescue medication for severe epilepsy in adults with learning disability. (9888498)
1998
40
Hypoxia induces intercellular adhesion molecule-1 on cultured human tubular cells. (9186857)
1997
41
Exploring the energy landscapes of molecular recognition by a genetic algorithm: analysis of the requirements for robust docking of HIV-1 protease and FKBP-12 complexes. (8844869)
1996
42
Surface plasmon resonance based kinetic studies of zinc finger-DNA interactions. (7602135)
1995
43
Enhancement of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by phorbol esters with and without activation of protein kinase C. (7540748)
1995
44
Retroperitoneal extragonadal germ cell tumor diagnosed by needle aspiration cytology and electron microscopy. (7484008)
1995
45
Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat. (2123806)
1990
46
Surveillance of Rocky Mountain spotted fever in the United States, 1978-1980. (7108278)
1982
47
Cardiovascular control in recently injured tetraplegics in spinal shock. (504551)
1979
48
Primary mucinous adenocarcinoma of the urinary bladder. (4354773)
1973
49
Dysthyroid exophthalmos. Palliation by lateral orbital decompression. (4161484)
1966
50
An operation for entropion in the dog. (20274656)
1946

Variations for Neurogenic Hypertension

About this section

Expression for genes affiliated with Neurogenic Hypertension

About this section
Search GEO for disease gene expression data for Neurogenic Hypertension.

Pathways for genes affiliated with Neurogenic Hypertension

About this section

GO Terms for genes affiliated with Neurogenic Hypertension

About this section

Sources for Neurogenic Hypertension

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet